primary care pharmacist

70
A Pharmacist in Primary Care? 16 th of May 2013. School of Pharmacy. University of Eastern Finland Carlos Barreda Velázquez Primary Care Pharmacist NorWest of Madrid E.mail: [email protected] Twiter: @ CarlosBarredav

Upload: carlos-barreda-velazquez

Post on 18-Aug-2015

28 views

Category:

Health & Medicine


1 download

TRANSCRIPT

Page 1: Primary care pharmacist

A Pharmacist in Primary Care?16th of May 2013. School of Pharmacy. University of Eastern Finland

Carlos Barreda VelázquezPrimary Care Pharmacist NorWest of Madrid

E.mail: [email protected] Twiter: @CarlosBarredav

Page 2: Primary care pharmacist
Page 3: Primary care pharmacist
Page 4: Primary care pharmacist

NORTHWEST HEALTH DISTRICT

Page 5: Primary care pharmacist

NORTHWEST HEALTH DISTRICT

Population: 975.400 inhabitants

40 HEALTH CENTERS

21 LOCAL SURGERIES

3 HOSPITALS

Page 6: Primary care pharmacist

HOSPITALS PRIMARY CARE

NATIONAL HEALTH SYSTEM

Page 7: Primary care pharmacist
Page 8: Primary care pharmacist
Page 9: Primary care pharmacist
Page 10: Primary care pharmacist

PROFESSIONALS

668 Doctors 502 Nurses

334 No health Professionals

87 Other Professionals

77 Emergency Service

14 Head Office

Page 11: Primary care pharmacist

What is a Primary Care Pharmacist?

Page 12: Primary care pharmacist
Page 13: Primary care pharmacist

Rational Use of Drugs

4.Drug Stock Management

3.Evaluate Prescription Indicators

2.Transfer Evidence to

Clinical Practice

1 Knowledge Management

in Drugs

Page 14: Primary care pharmacist

EFFICACYSAFETY

ADHERENCE COST

RATIONAL USE OF DRUGS

Page 15: Primary care pharmacist

EVIDENCE BASED MEDICINE

Page 16: Primary care pharmacist

But, but …what is a Primary Care Pharmacist?

Page 17: Primary care pharmacist
Page 18: Primary care pharmacist

Rational Use of Drugs

4.Drug Stock Management

3.Evaluate Prescription Indicators

2.Transfer Evidence to

Clinical Practice

1.Knowledge Management

in Drugs

Page 19: Primary care pharmacist

INFORMATION

Page 20: Primary care pharmacist

INFORMATION

And Sometimes who Provides that information?

Primary Care Pharmacist give scientific, objective and corroborated information

Page 22: Primary care pharmacist

Drugs Evaluations

WRITTEN INFORMATION

Page 24: Primary care pharmacist

CLINICAL QUESTIONS

What is the evidence for lowering cholesterol and using statins in stroke patients?

Page 25: Primary care pharmacist

Rational Use of Drugs

4.Drug Stock Management

3.Evaluate Prescription Indicators

2.Transfer Evidence to

Clinical Practice

1.Knowledge Management

in Drugs

Page 26: Primary care pharmacist

Education and training for local prescribers and other healthcare professionals

EDUCATION

PLACE OF WORK

Page 27: Primary care pharmacist

EDUCATION

Continued Education Programs

Education Programs to Residents and Interns (Family doctors and Hospital Pharmacists)

Patients Education Programs

Page 28: Primary care pharmacist

FUNDACIÓN JIMÉNEZ DÍAZ

HOSPITAL PUERTA DE HIERRO

HOSPITAL DE EL ESCORIAL

CARE COORDINATION

Page 29: Primary care pharmacist

Local Protocols

CARE COORDINATION

Rationale Use of Drugs Commission

Page 30: Primary care pharmacist

Local Protocols

CARE COORDINATION

Page 31: Primary care pharmacist

Rational Use of Drugs

4.Drug Stock Management

3.Evaluate Prescription Indicators

2.Transfer Evidence to

Clinical Practice

1.Knowledge Management

in Drugs

Page 32: Primary care pharmacist

HEALTH CENTER TARGETS

Ensuring that local prescribing is evidence-based and follows best practice

Prescribing indicators

Page 33: Primary care pharmacist

PRESCRIBING INDICATORS

SAFETY

EFFICACY

EFFECTIVENESS

EFFICIENCY

Page 34: Primary care pharmacist

DA % ARA II

Importe envase Estatina

Osteoporosis mujeres de 40 a 65 años

AINE en

anciano%NuevoACO

% PacSYSADOA

% Omepraz

DHD UPP (**) IBP

DA 42,45% 7,24 4,32% 9,64% 4,74% 10,13% 87,67% 15,21

DA 41,37% 7,74 2,95% 10,63% 6,37% 9,55% 87,72% 15,99

DA 42,79% 7,65 3,05% 8,61% 4,17% 9,43% 87,25% 14,15

DA 45,03% 9,11 4,24% 9,13% 3,94% 8,22% 83,27% 14,27

DA 39,27% 7,95 3,66% 9,68% 2,04% 6,77% 86,39% 18,37

DA 30,79% 6,23 3,25% 10,48% 2,10% 5,37% 86,96% 16,67

DA 39,38% 8,59 3,80% 11,08% 2,46% 8,62% 87,04% 17,74

A. Primaria 40,39% 7,78 3,64% 10,08% 3,89% 8,42% 86,80% 15,92

Page 35: Primary care pharmacist

IndicatorPromote ACE inhibitors vs ARBs

Cost-effective indicator

DDD ARBs

DDD ACEI + DDDARBS

AS AN EXAMPLE…

Page 36: Primary care pharmacist

In The 90s Primary Care Pharmacist was considered…

Page 37: Primary care pharmacist
Page 38: Primary care pharmacist
Page 39: Primary care pharmacist

Educational outreach visits: Trained Professiol visit Prescriber in Healthcare

FACE TO FACE

Page 40: Primary care pharmacist
Page 41: Primary care pharmacist

Pharmacists have changed

Page 42: Primary care pharmacist

Rational Use of Drugs

4.Drug Stock Management

3.Evaluate Prescription Indicators

2.Transfer Evidence to

Clinical Practice

1 Knowledge Management

in Drugs

Page 43: Primary care pharmacist

Storehouse(Pharmacy

Service)

H.C.

H.CH.C

Supplying medicines to Health Centers

Page 44: Primary care pharmacist

Which Medicines?

Crash Cart

Vaccines

Cares

Emergency Drugs

Page 45: Primary care pharmacist

Which Medicines?

Page 46: Primary care pharmacist

INSPECTION

Page 47: Primary care pharmacist

Rational Use of Drugs

4.Drug Stock Management

3.Evaluate Prescription Indicators

2.Transfer Evidence to

Clinical Practice

1 Knowledge Management

in Drugs

Page 48: Primary care pharmacist

SafeUse of Drugs

4.Drug Stock Management

3.Evaluate Prescription Indicators

2.Transfer Evidence to

Clinical Practice

1 Knowledge Management

in Drugs

Page 49: Primary care pharmacist

RISKS…?

Page 50: Primary care pharmacist

Polypharmacy in elderly people

IMPROVE THE QUALITY OF LIFE IN OVER 75 PATIENTS TAKING 5 OR MORE DRUGS

Page 51: Primary care pharmacist

1) Treatment Review

+

Polypharmacy in elderly people

2) Patient Education

+

3) Adherence

Page 52: Primary care pharmacist

INFORMATIC APPLICATIONS

INTERACTIONSMAXIMUM DOSES

Page 53: Primary care pharmacist

Treatment should be stopped if the patient develops ischaemic heart disease, peripheral arterial disease or cerebrovascular disease or if hypertension becomes uncontrolled..

STRONTIUM RANELATE

Page 54: Primary care pharmacist

MEDICATIONS ERRORS

Page 55: Primary care pharmacist

MEDICATIONS ERRORS

Page 56: Primary care pharmacist

DOSIS DEL PACIENTE

F. Organizativos y estratégicos

F. Ligados a la tarea

F. Recursos Condiciones de trabajo

F. Profesionales

Carga de trabajo?

Fatiga, cansancio ligada al turno/horario?

F. comunicación

F. Formación y conocimientos

F. Equipo y sociales F. paciente

Falta de manejo de dosis y presentacioens

Escasez de tiempo por Paciente?

OrganizaciónDe la consulta???

Falta de Comunicación del Protocolo.

Poca implicación del paciente porTratarse de un proceso agudo pocorelevante

Distracción

Falta de formació nen antimicrobianos

Falta de medidas de Adecuadas para la Implantación y Monitorización de los Protocolos

Falta de Incorporación de los Procedimientos a la Práctica Clínica

Falta de manejo de dosis y presentacioens

MEDICATIONS ERRORS

Page 57: Primary care pharmacist

1 MEDICATION ERROR

?????????????

Page 58: Primary care pharmacist

MEDICATIONS ERRORS

Patient Safety Good Clinical Practices

Page 59: Primary care pharmacist

MEDICATIONS ERRORS

Page 60: Primary care pharmacist

Woman 65 years Candida infection of the skinKetoconazol gel 2% is prescribed

MISTAKE REPORTED

Page 61: Primary care pharmacist

Patient used the medication as a shower gel

What it happened?

Page 62: Primary care pharmacist

Is a formal process in which healthcare providers work together in avoid Medicatio Errors origined across transitions of care

MEDICATION RECONCILATION

Page 63: Primary care pharmacist

MEDICATION RECONCILATION

1. Develop a list of current medications; 2. Develop a list of medications to be prescribed; 3. Compare the medications on the two lists 4. Make clinical decisions based on the comparison 5. Communicate the new list to appropriate caregivers and to the patient.

Page 64: Primary care pharmacist

NEW CHALLENGES

PRESCRIPTION CARD

Page 65: Primary care pharmacist
Page 66: Primary care pharmacist

TREATMENT REVIEWS

Page 67: Primary care pharmacist
Page 68: Primary care pharmacist
Page 69: Primary care pharmacist

http://populationpyramid.net/WORLD/2010/

FINLANDSPAIN

Page 70: Primary care pharmacist

THANK YOU VERY MUCH!!!!